4DX — 4DMedical Share Price
Last Trade - 00:00- AU$402.44m
- AU$360.18m
- AU$1.23m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | n/a | 0.68 | 1.38 | 0.69 | 1.23 | 2.15 | 3.74 | 21.81% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
4DMedical Limited is an Australia-based medical technology company. The Company offers XV Technology. The XV Technology is a four-dimensional lung imaging technology that utilizes mathematic models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing X-ray machines. Using specific settings and protocols, the data from a patient’s X-ray images are sent to the 4DMedical cloud where it is analyzed by 4DMedical and returned to the physician as a comprehensive report of quantitative four-dimensional lung function data. The ventilation analysis performed by XV Ventilation Analysis provides physicians with a patient’s regional measurements of ventilation at each phase of the breath, delivering functional data on lung health.
Directors
- Last Annual
- June 30th, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- January 1st, 1970
- Public Since
- January 1st, 1970
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 264,762,405
- Address
- 5/468 St. Kilda Road, MELBOURNE, 3004
- Web
- https://4dmedical.com/
- Phone
- +61 395455940
- Auditors
- PKF Melbourne Audit & Assurance Pty Ltd
Latest News for 4DX
Upcoming events for 4DX
Full Year 2021 4DMedical Ltd Earnings Release
4DMedical Ltd Annual Shareholders Meeting
Similar to 4DX
ADHERIUM ORD
Australian Stock Exchange - SEATS
ATOMO DIAGNOSTICS ORD
Australian Stock Exchange - SEATS
BLUECHIIP ORD
Australian Stock Exchange - SEATS
CARDIEX ORD
Australian Stock Exchange - SEATS
COMPUMEDICS ORD
Australian Stock Exchange - SEATS
FAQ
As of Today at 11:30 UTC, shares in 4DMedical are trading at AU$1.52. This share price information is delayed by 15 minutes.
Shares in 4DMedical last closed at AU$1.52 and the price had moved by -9.52% over the past 365 days. In terms of relative price strength the 4DMedical share price has underperformed the ASX All Ordinaries Index by -27.75% over the past year.
The overall consensus recommendation for 4DMedical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
4DMedical does not currently pay a dividend.
4DMedical does not currently pay a dividend.
4DMedical does not currently pay a dividend.
To buy shares in 4DMedical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$1.52, shares in 4DMedical had a market capitalisation of AU$402.44m.
Here are the trading details for 4DMedical:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: 4DX
Shares are classified based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
4DMedical does not currently have a style classification.
The analyst consensus target price for shares in 4DMedical is AU$1.80. That is 18.42% above the last closing price of AU$1.52.
Analysts covering 4DMedical currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.05 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 4DMedical. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -26.46%.
As of the last closing price of AU$1.52, shares in 4DMedical were trading -14.39% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for 4DMedical.
We do not have data on 4DMedical's directors
We do not have data on 4DMedical's shareholders